195 related articles for article (PubMed ID: 29362810)
1. Predictive Model for Response Rate to Narrowband Ultraviolet B Phototherapy in Vitiligo: A Retrospective Cohort Study of 579 Patients.
Cabrera R; Hojman L; Recule F; Sepulveda R; Delgado I
Acta Derm Venereol; 2018 Apr; 98(4):416-420. PubMed ID: 29362810
[TBL] [Abstract][Full Text] [Related]
2. Impact of Ultraviolet Light on Vitiligo.
Singh RK
Adv Exp Med Biol; 2017; 996():55-60. PubMed ID: 29124690
[TBL] [Abstract][Full Text] [Related]
3. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.
Natta R; Somsak T; Wisuttida T; Laor L
J Am Acad Dermatol; 2003 Sep; 49(3):473-6. PubMed ID: 12963911
[TBL] [Abstract][Full Text] [Related]
4. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
[TBL] [Abstract][Full Text] [Related]
5. Low-dose UVB therapy is comparable with conventional UVB phototherapy for treatment of vitiligo: A pilot study.
Chiu SH; Liu IL; Chen YW; Lan CE
J Dermatol Sci; 2018 Nov; 92(2):218-220. PubMed ID: 30227989
[No Abstract] [Full Text] [Related]
6. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P; Klahan SO
Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous improvement and worsening of vitiligo lesions during the course of NB-UVB phototherapy; vitiligo may not act as one unit.
Anbar T; Abdel-Rahman A; Hegazy R; El-Khayyat M; Ragaie M
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27611118
[TBL] [Abstract][Full Text] [Related]
8. Narrowband UVB phototherapy in vitiligo: evaluation of results in 53 patients.
Percivalle S; Piccino R; Caccialanza M; Forti S
G Ital Dermatol Venereol; 2008 Feb; 143(1):9-14. PubMed ID: 18833047
[TBL] [Abstract][Full Text] [Related]
9. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
Bansal S; Sahoo B; Garg V
Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
[TBL] [Abstract][Full Text] [Related]
10. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients.
Yang YS; Cho HR; Ryou JH; Lee MH
Int J Dermatol; 2010 Mar; 49(3):317-23. PubMed ID: 20465673
[TBL] [Abstract][Full Text] [Related]
11. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.
Kanwar AJ; Dogra S; Parsad D; Kumar B
Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664
[TBL] [Abstract][Full Text] [Related]
12. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
Sapam R; Agrawal S; Dhali TK
Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
[TBL] [Abstract][Full Text] [Related]
13. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
14. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial.
Zabolinejad N; Maleki M; Salehi M; Ashrafi Z; Molkara S; Layegh P
Australas J Dermatol; 2020 Feb; 61(1):e65-e69. PubMed ID: 31651037
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: A randomized, double-blind, placebo-controlled trial.
Charoenpongpun N; Kamanamool N; Udompataikul M; Khunkhet S; Kanokrungsee S
Dermatol Ther; 2022 Aug; 35(8):e15596. PubMed ID: 35608017
[TBL] [Abstract][Full Text] [Related]
16. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
17. Narrow-band UVB treatment of vitiligo in Chinese.
Chen GY; Hsu MM; Tai HK; Chou TC; Tseng CL; Chang HY; Lan CC; Sheu HM
J Dermatol; 2005 Oct; 32(10):793-800. PubMed ID: 16361730
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
[TBL] [Abstract][Full Text] [Related]
19. The Role of CXCL10 and IL-18 as Markers of Repigmentation Response in Nonsegmental Vitiligo Treated with Narrowband UVB Phototherapy: A Prospective Cohort Study.
Hojman L; Cabrera R; Karsulovic C; Tempio F; Perez C; López M
J Invest Dermatol; 2021 Jul; 141(7):1833-1836.e1. PubMed ID: 33453262
[No Abstract] [Full Text] [Related]
20. Phototherapy for Vitiligo: A Systematic Review and Meta-analysis.
Bae JM; Jung HM; Hong BY; Lee JH; Choi WJ; Lee JH; Kim GM
JAMA Dermatol; 2017 Jul; 153(7):666-674. PubMed ID: 28355423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
